Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 22% ± 5% | |
| astrocyte | 5 studies | 33% ± 12% | |
| epithelial cell | 4 studies | 34% ± 4% | |
| oligodendrocyte precursor cell | 4 studies | 32% ± 8% | |
| oligodendrocyte | 4 studies | 24% ± 6% | |
| type I pneumocyte | 3 studies | 18% ± 1% | |
| GABAergic neuron | 3 studies | 48% ± 5% | |
| glutamatergic neuron | 3 studies | 57% ± 8% | |
| macrophage | 3 studies | 20% ± 3% | |
| basal cell | 3 studies | 28% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 44% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1101.32 | 1445 / 1445 | 100% | 16.74 | 183 / 183 |
| prostate | 100% | 1174.04 | 245 / 245 | 100% | 20.56 | 502 / 502 |
| breast | 100% | 1080.26 | 459 / 459 | 100% | 18.58 | 1116 / 1118 |
| lung | 100% | 943.05 | 577 / 578 | 100% | 13.01 | 1152 / 1155 |
| uterus | 100% | 1097.48 | 170 / 170 | 100% | 12.68 | 457 / 459 |
| ovary | 100% | 1143.09 | 180 / 180 | 100% | 10.37 | 428 / 430 |
| thymus | 100% | 1222.04 | 653 / 653 | 100% | 15.12 | 602 / 605 |
| pancreas | 100% | 680.43 | 328 / 328 | 99% | 11.98 | 177 / 178 |
| brain | 99% | 616.84 | 2627 / 2642 | 100% | 13.25 | 705 / 705 |
| bladder | 100% | 932.10 | 21 / 21 | 99% | 11.75 | 497 / 504 |
| intestine | 100% | 1016.21 | 966 / 966 | 98% | 12.50 | 518 / 527 |
| stomach | 100% | 799.52 | 359 / 359 | 98% | 13.01 | 281 / 286 |
| kidney | 100% | 750.37 | 89 / 89 | 98% | 13.13 | 884 / 901 |
| adrenal gland | 100% | 998.00 | 258 / 258 | 97% | 10.29 | 224 / 230 |
| liver | 100% | 716.73 | 226 / 226 | 97% | 8.85 | 392 / 406 |
| skin | 100% | 1232.61 | 1809 / 1809 | 95% | 10.56 | 450 / 472 |
| adipose | 100% | 932.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 940.09 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 9.47 | 29 / 29 |
| muscle | 100% | 1170.08 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 705.21 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 13.48 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.44 | 1 / 1 |
| heart | 96% | 623.86 | 825 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 84% | 6.88 | 67 / 80 |
| peripheral blood | 67% | 523.86 | 620 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0097111 | Biological process | endoplasmic reticulum-Golgi intermediate compartment organization |
| GO_0034497 | Biological process | protein localization to phagophore assembly site |
| GO_0006886 | Biological process | intracellular protein transport |
| GO_0016240 | Biological process | autophagosome membrane docking |
| GO_0007030 | Biological process | Golgi organization |
| GO_0006887 | Biological process | exocytosis |
| GO_0048278 | Biological process | vesicle docking |
| GO_0006888 | Biological process | endoplasmic reticulum to Golgi vesicle-mediated transport |
| GO_0006906 | Biological process | vesicle fusion |
| GO_0097352 | Biological process | autophagosome maturation |
| GO_0030897 | Cellular component | HOPS complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0012505 | Cellular component | endomembrane system |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0000421 | Cellular component | autophagosome membrane |
| GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
| GO_0030868 | Cellular component | smooth endoplasmic reticulum membrane |
| GO_0044233 | Cellular component | mitochondria-associated endoplasmic reticulum membrane contact site |
| GO_0005829 | Cellular component | cytosol |
| GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
| GO_0005776 | Cellular component | autophagosome |
| GO_0030134 | Cellular component | COPII-coated ER to Golgi transport vesicle |
| GO_0012507 | Cellular component | ER to Golgi transport vesicle membrane |
| GO_0005791 | Cellular component | rough endoplasmic reticulum |
| GO_0031201 | Cellular component | SNARE complex |
| GO_0005765 | Cellular component | lysosomal membrane |
| GO_0019903 | Molecular function | protein phosphatase binding |
| GO_0019901 | Molecular function | protein kinase binding |
| GO_0000149 | Molecular function | SNARE binding |
| GO_0005484 | Molecular function | SNAP receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | STX17 |
| Protein name | Syntaxin 17 Syntaxin-17 STX17 protein |
| Synonyms | |
| Description | FUNCTION: SNAREs, soluble N-ethylmaleimide-sensitive factor-attachment protein receptors, are essential proteins for fusion of cellular membranes. SNAREs localized on opposing membranes assemble to form a trans-SNARE complex, an extended, parallel four alpha-helical bundle that drives membrane fusion . STX17 is a SNARE of the autophagosome involved in autophagy through the direct control of autophagosome membrane fusion with the lysosome membrane . May also play a role in the early secretory pathway where it may maintain the architecture of the endoplasmic reticulum-Golgi intermediate compartment/ERGIC and Golgi and/or regulate transport between the endoplasmic reticulum, the ERGIC and the Golgi . . |
| Accessions | P56962 ENST00000525342.5 Q2TAB5 ENST00000526607.1 ENST00000529340.5 ENST00000524405.5 Q6NSC7 ENST00000525640.5 ENST00000259400.11 ENST00000531035.5 E9PQU9 E9PJW1 E9PIC2 ENST00000534052.1 E9PJV6 |
